Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

NCT03164486 is registered in ClinicalTrials.gov with Julie L. Sutcliffe, Ph.D as lead sponsor.

NCT NCT03164486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03164486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Lead sponsor
Julie L. Sutcliffe, Ph.D
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 30, 2016
Completion date
December 31, 2026
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, colorectal carcinoma, lung carcinoma, metastatic malignant neoplasm in the breast, metastatic malignant neoplasm in the colon, metastatic malignant neoplasm in the lung, metastatic malignant neoplasm in the rectum, pancreatic carcinoma